Written question asked by Nick Harvey (Liberal Democrat) on Tuesday, 13 November 2001, in the House of Commons. It was due for an answer on Monday, 3 December 2001. It was answered by Hazel Blears (Labour) on Monday, 3 December 2001 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what recent representations he has received from the pharmaceutical industry about compliance with the Labels and Leaflets Directive (Directive 92/27/EEC); what steps his Department takes to ensure that patients receive the information required by the Labels and Leaflets Directive (Directive 92/27EEC) when a prescription medicine is dispensed; if he will list the information that is required to be provided to a patient about a prescription medicine when it is dispensed and the form in which that information should be provided; what guidance (a) his Department and (b) its agencies have issued to pharmacists to ensure that they comply with the Labels and Leaflets Directive (Directive 92/27/EEC) when dispensing a prescription medicine; what steps he will take to ensure that patients receive the information that is required by the Labels and Leaflets Directive (92/27/EEC) when prescription medicines are dispensed. - Including ref to Medicines for Human Use (Marketing Authorisations Etc) Regulations 1994 and Directive 92/27/EEC, copies in Library.

Secondary information

Type: Written question
Reference: 376 c125-6W;376 c126W; 15659;15657;15660;15658;18392
Session: 2001-02
EC documents: DIR92/27/EEC
Subjects: EU law Drugs Industry Labelling EU action Leaflets Prescription drugs Packaging Standardisation
Link: View this Written question on www.publications.parliament.uk